Related Experiment Video
Updated: Jul 28, 2026
10:42
Design to Implementation Study for Development and Patient Validation of Paper-Based Toehold Switch Diagnostics
Published on: June 17, 2022
Connectivity: the key to point-of-care testing
Medical Device Technology
|August 26, 2004
Summary
Advances in whole blood sensing require information technology improvements for point-of-care testing growth. A universal connectivity standard is being developed to replace incompatible proprietary systems, enhancing data management.
Area of Science:
- Biomedical engineering
- Medical diagnostics
- Information technology
Background:
- The point-of-care testing market requires integrated analytical devices and data management systems for growth.
- Current proprietary and incompatible solutions hinder seamless data integration and workflow efficiency.
Purpose of the Study:
- To highlight the necessity of information technology advancements alongside whole blood sensing technology for successful point-of-care testing market expansion.
- To introduce the development of a common connectivity standard for analytical instruments.
Main Methods:
- Review of current technological limitations in point-of-care testing connectivity.
- Analysis of the need for standardized data management in diagnostic devices.
- Description of efforts to develop a universal instrument connectivity standard.
Main Results:
- Successful growth in point-of-care testing is contingent upon synergistic advancements in sensing technology and information technology.
- A common connectivity standard is under development to address the limitations of existing proprietary systems.
Conclusions:
- Information technology improvements, particularly a common connectivity standard, are crucial for the successful integration and data management of point-of-care testing devices.
- Standardization will facilitate broader adoption and enhance the utility of point-of-care diagnostics.
Related Concept Videos
01:33Enzyme-Linked Immunosorbent Assay
In 1971, Peter Perlman and Eva Engvall developed an Enzyme-linked immunosorbent assay (ELISA or EIA). ELISA differs from western blot in that the assays are conducted in microtiter plates or in vivo rather than on an absorbent membrane.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
There are many different types of ELISAs, but they all involve an antibody molecule whose constant region binds an enzyme, leaving the variable region free to bind its specific antigen. Enzyme-substrate reaction allows the antigen to be visualized or quantified.
01:13Sensitivity, Specificity, and Predicted Value
In healthcare diagnostics, laboratory tests play a crucial role in identifying and diagnosing a wide range of medical conditions. However, interpreting test results is not always straightforward. An abnormal test result does not always confirm the presence of a disease, just as a normal result does not guarantee its absence. To assess the reliability of these diagnostic tools, healthcare practitioners rely on two key statistical indicators: sensitivity and specificity.
Sensitivity is the...
Sensitivity is the...
01:24Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...